Control-IQ Observational (CLIO) Post-Approval Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Post-approval 522 study designed to collect primarily safety data on the US FDA-cleared product, t:slim X2 insulin pump with Control-IQ technology (Control-IQ system).
Epistemonikos ID: 6a2d53b25d95799a5fe0cbc4d9888a726f68512d
First added on: May 07, 2024